Evidence map›Paper›PMID 37755077›Full record

ArticleMarine drugs2023

A Compared Study of Eicosapentaenoic Acid and Docosahexaenoic Acid in Improving Seizure-Induced Cognitive Deficiency in a Pentylenetetrazol-Kindling Young Mice Model.

Yueqi Yang, Xueyan Wang, Lu Chen, Shiben Wang, Jun Han, Zhengping Wang, Min Wen

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yueqi YangInstitute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, China.
Xueyan WangInstitute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, China.
Lu ChenInstitute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, China.
Shiben WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252059, China.
Jun HanInstitute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, China.
Zhengping WangInstitute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, China.
Min WenInstitute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, China.ORCID 0000-0001-8897-1239
Liaocheng University · CN

Funding

Natural Science Foundation of Shandong province ZR2021QH022Open Project of Liaocheng University Animal Husbandry Discipline No. 319462207-24
6 · The paper itself

Abstract

Epilepsy is a chronic neurological disorder that is more prevalent in children, and recurrent unprovoked seizures can lead to cognitive impairment. Numerous studies have reported the benefits of docosahexaenoic acid (DHA) on neurodevelopment and cognitive ability, while comparatively less attention has been given to eicosapentaenoic acid (EPA). Additionally, little is known about the effects and mechanisms of DHA and EPA in relation to seizure-induced cognitive impairment in the young rodent model. Current research indicates that ferroptosis is involved in epilepsy and cognitive deficiency in children. Further investigation is warranted to determine whether EPA or DHA can mitigate seizure-induced cognitive deficits by inhibiting ferroptosis. Therefore, this study was conducted to compare the effects of DHA and EPA on seizure-induced cognitive deficiency and reveal the underlying mechanisms focused on ferroptosis in a pentylenetetrazol (PTZ)-kindling young mice model. Mice were fed a diet containing DHA-enriched ethyl esters or EPA-enriched ethyl esters for 21 days at the age of 3 weeks and treated with PTZ (35 mg/kg, i.p.) every other day 10 times. The findings indicated that both EPA and DHA exhibited ameliorative effects on seizure-induced cognitive impairment, with EPA demonstrating a superior efficacy. Further mechanism study revealed that supplementation of DHA and EPA significantly increased cerebral DHA and EPA levels, balanced neurotransmitters, and inhibited ferroptosis by modulating iron homeostasis and reducing lipid peroxide accumulation in the hippocampus through activating the Nrf2/Sirt3 signal pathway. Notably, EPA exhibited better an advantage in ameliorating iron dyshomeostasis compared to DHA, owing to its stronger upregulation of Sirt3. These results indicate that DHA and EPA can efficaciously alleviate seizure-induced cognitive deficiency by inhibiting ferroptosis in PTZ-kindled young mice.

Indexed as

PentylenetetrazoleSirtuin 3AnimalsChildCognitionDisease Models, AnimalDocosahexaenoic AcidsEicosapentaenoic AcidHumansInfant, NewbornMiceSeizuresDocosahexaenoic AcidsEicosapentaenoic AcidPentylenetetrazoleSirtuin 3cognitive deficiencyDHAEPAepilepsyferroptosisyoung mice

Identifiers

PMID37755077
PMCPMC10533149
OpenAlexW4386168445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.